Oramed Pharmaceutical Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Jerusalem Israel (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2008
NCT00867594
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Oramed, Ltd. | Oramed Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

insulin human (humulin) (9 trials)

Drugs in Phase 2 Trials (1)

Insulin, bovine (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 3)

Fatty Liver (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 2